DXB 6.67% 35.0¢ dimerix limited

My take is the previous Poor management, endless CR, at low...

  1. 3,274 Posts.
    lightbulb Created with Sketch. 80
    My take is the previous Poor management, endless CR, at low prices and at in-opportune times, difficulty with portraying a clear commercial opportunity for SH. Could it be that the current Management team are rowing up opportunities behind the scenes and will come forward with a flurry of announcements and news? this why I took a position https://hotcopper.com.au/threads/ann-dmx-200-phase-2a-data-presentation.3807672/#.Wp3yh2puaM8

    The company could raise its profile but needs to convey a strong business message to the wider market?? other than that it's a wait and see, Only positive trial data progresses the SP in the Bio-tech sector..would you rather have Hype? and Fluff? i would prefer bankable facts ...
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.025(6.67%)
Mkt cap ! $25.68M
Open High Low Value Volume
37.0¢ 37.0¢ 35.0¢ $387.8K 1.079M

Buyers (Bids)

No. Vol. Price($)
11 394907 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
36.5¢ 15948 1
View Market Depth
Last trade - 16.10pm 12/12/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.